{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:12:39Z","timestamp":1779246759614,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejphar.2020.173780","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T11:15:59Z","timestamp":1606734959000},"page":"173780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Limitations of an ex vivo breast cancer model for studying the mechanism of action of the anticancer drug paclitaxel"],"prefix":"10.1016","volume":"891","author":[{"given":"Alicja","family":"Urbaniak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Pi\u00f1a-Oviedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7681-2756","authenticated-orcid":false,"given":"Youzhong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Huczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173780_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cm.1016","article-title":"Centrosome and spindle pole microtubules are main targets of a fluorescent taxoid inducing cell death","volume":"49","author":"Abal","year":"2001","journal-title":"Cell Motil Cytoskeleton"},{"key":"10.1016\/j.ejphar.2020.173780_bib2","first-page":"589","article-title":"Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay","volume":"48","author":"Alley","year":"1988","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2020.173780_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejmech.2014.02.031","article-title":"Synthesis, cytotoxicity and antibacterial activity of new esters of polyether antibiotic - salinomycin","volume":"76","author":"Antoszczak","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173780_bib4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ejmech.2018.07.021","article-title":"Biological activity of doubly modified salinomycin analogs - evaluation in vitro and ex vivo","volume":"156","author":"Antoszczak","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173780_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bcp.13126","article-title":"Microtubule destabilising agents: far more than just antimitotic anticancer drugs","volume":"83","author":"Bates","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejphar.2020.173780_bib6","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3390\/cells8121501","article-title":"Diversity of the senescence phenotype of cancer cells treated with chemotherapeutic agents","volume":"8","author":"Bojko","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2020.173780_bib7","first-page":"73","article-title":"Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach","volume":"11","author":"Carlson","year":"2011","journal-title":"Clin. Breast Canc."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173780_bib48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cmdc.201900593","article-title":"Synthesis and Anticancer Activity of Tertiary Amides of Salinomycin and Their C20-oxo Analogues","volume":"15","author":"Czerwonka","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejphar.2020.173780_bib8","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1158\/0008-5472.CAN-11-1417","article-title":"Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer","volume":"71","author":"Darshan","year":"2011","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2020.173780_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bcp.2018.12.015","article-title":"Contrasting effects of microtubule destabilizers versus stabilizers on induction of death in G1 phase of the cell cycle","volume":"162","author":"Delgado","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173780_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ijc.24999","article-title":"Cell line cross-contamination initiative: an interactive reference database of STR profiles covering common cancer cell lines","volume":"126","author":"Dirks","year":"2010","journal-title":"International journal of cancer Journal international du cancer"},{"key":"10.1016\/j.ejphar.2020.173780_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.6004\/jnccn.2016.0007","article-title":"Prevalence and safety of off-label use of chemotherapeutic agents in older patients with breast cancer: estimates from SEER-medicare data","volume":"14","author":"Eaton","year":"2016","journal-title":"J. Natl. Compr. Canc. Netw. : J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.ejphar.2020.173780_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11040178","article-title":"Short and long-term effects of the exposure of breast cancer cell lines to different ratios of free or Co-encapsulated liposomal paclitaxel and doxorubicin","volume":"11","author":"Franco","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2020.173780_bib13","first-page":"478","article-title":"A new perspective on old drugs: non-mitotic actions of tubulin-binding drugs play a major role in cancer treatment","volume":"68","author":"Furst","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejphar.2020.173780_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/35036335","article-title":"p53 is associated with cellular microtubules and is transported to the nucleus by dynein","volume":"2","author":"Giannakakou","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2020.173780_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","article-title":"Identification of selective inhibitors of cancer stem cells by high-throughput screening","volume":"138","author":"Gupta","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173780_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1634\/stemcells.19-1-88","article-title":"The cell cycle","volume":"19","author":"Israels","year":"2001","journal-title":"Stem Cell."},{"key":"10.1016\/j.ejphar.2020.173780_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrc2049","article-title":"Targeted anti-mitotic therapies: can we improve on tubulin agents?","volume":"7","author":"Jackson","year":"2007","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejphar.2020.173780_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejphar.2020.173780_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.82","article-title":"Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells","volume":"6","author":"Kavanagh","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ejphar.2020.173780_bib20","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nrclinonc.2010.228-c1","article-title":"Too early to say, \u201cno targeting of mitosis!\u201d","volume":"8","author":"Kitagawa","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2020.173780_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrclinonc.2010.228","article-title":"Mitosis is not a key target of microtubule agents in patient tumors","volume":"8","author":"Komlodi-Pasztor","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2020.173780_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1078-0432.CCR-11-0999","article-title":"Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale","volume":"18","author":"Komlodi-Pasztor","year":"2012","journal-title":"Clin. Canc. Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.ejphar.2020.173780_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7169","article-title":"Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity","volume":"6","author":"Majumder","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2020.173780_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2011.197","article-title":"Killing cells by targeting mitosis","volume":"19","author":"Manchado","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2020.173780_bib25","first-page":"96","article-title":"Taxanes, microtubules and chemoresistant breast cancer","volume":"1785","author":"McGrogan","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2020.173780_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1091\/mbc.e10-04-0335","article-title":"The proliferation rate paradox in antimitotic chemotherapy","volume":"23","author":"Mitchison","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejphar.2020.173780_bib27","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1158\/1078-0432.CCR-07-0009","article-title":"Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy","volume":"13","author":"Olofsson","year":"2007","journal-title":"Clin. Canc. Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.ejphar.2020.173780_bib28","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1073\/pnas.1416418112","article-title":"Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins","volume":"112","author":"Poruchynsky","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"6","key":"10.1016\/j.ejphar.2020.173780_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41416-019-0672-6","article-title":"Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery","volume":"122","author":"Powley","year":"2020","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejphar.2020.173780_bib30","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/sj.bjc.6605419","article-title":"Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro","volume":"101","author":"Prencipe","year":"2009","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejphar.2020.173780_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.devcel.2004.09.002","article-title":"Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint","volume":"7","author":"Rieder","year":"2004","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ejphar.2020.173780_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1600-0854.2007.00564.x","article-title":"A microtubule-facilitated nuclear import pathway for cancer regulatory proteins","volume":"8","author":"Roth","year":"2007","journal-title":"Traffic"},{"key":"10.1016\/j.ejphar.2020.173780_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.med.48.1.353","article-title":"The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents","volume":"48","author":"Rowinsky","year":"1997","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2020.173780_bib34","series-title":"The Chemotherapy Source Book","first-page":"387","author":"Rowinsky","year":"1998"},{"key":"10.1016\/j.ejphar.2020.173780_bib35","first-page":"1","article-title":"Clinical toxicities encountered with paclitaxel (Taxol)","volume":"20","author":"Rowinsky","year":"1993","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejphar.2020.173780_bib36","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by taxol","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173780_bib37","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1073\/pnas.77.3.1561","article-title":"Taxol stabilizes microtubules in mouse fibroblast cells","volume":"77","author":"Schiff","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejphar.2020.173780_bib38","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ceb.2013.07.003","article-title":"Mitosis and apoptosis: how is the balance set?","volume":"25","author":"Topham","year":"2013","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejphar.2020.173780_bib39","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-12-1041","article-title":"Tales of how great drugs were brought down by a flawed rationale--letter","volume":"19","author":"Tunquist","year":"2013","journal-title":"Clin. Canc. Res. : an official journal of the American Association for Cancer Research"},{"issue":"6","key":"10.1016\/j.ejphar.2020.173780_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22487","article-title":"Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells-in vitro and ex vivo study","volume":"34","author":"Urbaniak","year":"2020","journal-title":"J Biochem Mol Toxicol ."},{"issue":"5","key":"10.1016\/j.ejphar.2020.173780_bib46","first-page":"5097","article-title":"The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex vivo study","volume":"18","author":"Urbaniak","year":"2019","journal-title":"Oncology Letters"},{"key":"10.1016\/j.ejphar.2020.173780_bib40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-6-86","article-title":"Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment","volume":"6","author":"van der Kuip","year":"2006","journal-title":"BMC Canc."},{"key":"10.1016\/j.ejphar.2020.173780_bib41","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejphar.2020.173780_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ccr.2005.06.011","article-title":"Decoding the links between mitosis, cancer, and chemotherapy: the mitotic checkpoint, adaptation, and cell death","volume":"8","author":"Weaver","year":"2005","journal-title":"Canc. Cell"},{"key":"10.1016\/j.ejphar.2020.173780_bib43","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1078-0432.CCR-12-2695","article-title":"Tales of how great drugs were brought down by a flawed rationale--letter","volume":"19","author":"Wissing","year":"2013","journal-title":"Clin. Canc. Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.ejphar.2020.173780_bib44","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1158\/1535-7163.MCT-06-0319","article-title":"Spindle checkpoint function and cellular sensitivity to antimitotic drugs","volume":"5","author":"Yamada","year":"2006","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173780_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007965","article-title":"Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles","volume":"6","author":"Zasadil","year":"2014","journal-title":"Sci. Transl. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:10:54Z","timestamp":1762143054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920308724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":48,"alternative-id":["S0014299920308724"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173780","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limitations of an ex vivo breast cancer model for studying the mechanism of action of the anticancer drug paclitaxel","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173780"}}